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The mechanism by which CD4 T cells are depleted
in HIV-infected hosts remains poorly understood.
In ex vivo cultures of human tonsil tissue, CD4
T cells undergo a pronounced cytopathic response
following HIV infection. Strikingly, >95% of these
dying cells are not productively infected but instead
correspond to bystander cells. We now show that
the death of these ‘‘bystander’’ cells involves abor-
tive HIV infection. Inhibitors blocking HIV entry or
early steps of reverse transcription prevent CD4
T cell death while inhibition of later events in the viral
life cycle does not. We demonstrate that the nonper-
missive state exhibited by themajority of resting CD4
tonsil T cells leads to accumulation of incomplete
reverse transcripts. These cytoplasmic nucleic acids
activate a host defense program that elicits a coordi-
nated proapoptotic and proinflammatory response
involving caspase-3 and caspase-1 activation. While
this response likely evolved to protect the host, it
centrally contributes to the immunopathogenic
effects of HIV.
INTRODUCTION
Despite extensive efforts over the past quarter century, the
precise mechanism by which HIV-1 causes progressive deple-
tion of CD4 T cells remains debated. Both direct and indirect
cytopathic effects have been proposed. When immortalized
T cell lines are infected with laboratory-adapted HIV-1 strains,
direct CD4 T cell killing predominates. Conversely, in more
physiological systems, such as infection of lymphoid tissue
with primary HIV-1 isolates, the majority of dying cells appear
as uninfected ‘‘bystander’’ CD4 T cells (Finkel et al., 1995; Jekle
et al., 2003).Various mechanisms have been proposed to contribute to
the death of these bystander CD4 T cells including the action
of host-derived factors like tumor necrosis factor-a, Fas ligand
and TRAIL (Gandhi et al., 1998; Herbeuval et al., 2005), and viral
factors like HIV-1 Tat, Vpr, and Nef released from infected cells
(Schindler et al., 2006; Westendorp et al., 1995). Considerable
interest has also focused on the role of gp120 and gp41 Env
protein in indirect cell death, although it is not clear whether
death signaling involves gp120 binding to its chemokine
receptor or gp41-mediated fusion. It is also unclear whether
such killing is caused by HIV-1 virions or by infected cells
expressing Env.
Most studies have focused on death mechanisms acting prior
to viral entry. Less is known about the fate of HIV-1-infected CD4
T cells that do not express viral genes, in particular naive CD4
T cells in tissue that are refractory to productive HIV infection
(Glushakova et al., 1995; Kreisberg et al., 2006). In these cells,
infection is aborted after viral entry, as reverse transcription is
initiated but fails to reach completion (Kamata et al., 2009;
Swiggard et al., 2004; Zack et al., 1990; Zhou et al., 2005).
Human lymphoid aggregated cultures (HLACs) prepared from
tonsillar tissue closely replicate the conditions encountered by
HIV in vivo and thus form an attractive, biologically relevant
system for studying HIV-1 infection (Eckstein et al., 2001).
Lymphoid organs are the primary sites of HIV replication and
contain more than 98% of the body’s CD4 T cells. Moreover,
events critical to HIV disease progression occur in lymphoid
tissues, where the network of cell-cell interactions mediating
the immune response deteriorates and ultimately collapses.
Primary cultures of peripheral blood cells do not fully mimic
the cytokine milieu, the cellular composition of lymphoid tissue,
nor the functional relationships that are undoubtedly important
in HIV pathogenesis. Finally, HLACs can be infected with
a low number of viral particles in the absence of artificial mito-
gens, allowing analysis of HIV cytopathicity in a natural and
preserved environment. In this study, we used the HLAC system
to explore the molecular basis for HIV-induced killing of CD4
T cells.Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc. 789
Figure 1. Massive Depletion of CD4 T Cells in HLACs Containing Small Number of Productively Infected Cells
Kinetics of spreading viral infection versus depletion of CD4 T cells after infection of HLACs with a replication-competent HIV reporter virus encoding GFP.
CD4 downregulation in GFP-positive cells likely represents the combined action of the HIV Nef, Vpu, and Env proteins expressed by this virus. Ratios of viable
CD4 versus CD8 T cells in HIV-infected and uninfected cultures are also shown. Flow cytometry plots represent live-gated cells, based on the forward-scatter
versus side-scatter profile of the complete culture. These data are the representative results of six independent experiments utilizing tonsil cells from six different
donors.RESULTS
Selective Depletion of CD4 T Cells by X4-Tropic HIV-1
To explore depletion of CD4 T cells by HIV-1, HLACs made from
freshly dissected human tonsillar tissues were infected with
a GFP reporter virus (NLENG1), prepared from the X4-tropic
NL4-3 strain of HIV-1. This reporter produces fully replication-
competent viruses. An IRES inserted upstream of the Nef gene
preserves Nef expression and supports LTR-driven GFP expres-
sion (Levy et al., 2004), allowing simultaneous quantification of
the dynamics of HIV-1 infection and T cell depletion. NL4-3790 Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc.was selected because tonsillar tissue contains a high per-
centage of CD4 T cells expressing CXCR4 (90%–100%).
Productively infected GFP-positive cells appeared in small
numbers 3 days after infection, peaked on days 6–9, and
decreased until day 12, when few CD4 T cells remained in the
culture (Figure 1). Fluorescence-linked antigen quantification
(FLAQ) assay of HIV-1 p24 (Hayden et al., 2003) confirmed the
accumulation of viral particles in the medium between day 3
and days 8 to 9, when a plateau was reached (data not shown).
Interestingly, when HIV-1 p24 levels plateaued no more than
1.5% of all cells (about 5% of CD4 T cells) were GFP-positive.
Figure 2. CD4 T Cell Depletion in HIV-1-Infected HLACs Predominantly Involves Nonproductively Infected Cells
(A) Experimental strategy to assess indirect cell killing in HIV-1-infected human lymphoid cultures. Fresh human tonsil tissue from a single donor is processed into
HLAC, and then separated into two fractions. One fraction is challengedwith HIV-1 and cultured for 6 days, allowing viral spread. On day 5, the uninfected fraction
is treated with AZT (5 mM) and labeled with CFSE (1 mM). On day 6, the infected and CFSE-labeled cultures are mixed and cocultured in the presence of AZT.
Because of its site of action, AZT does not block viral output from the HIV-infected cells but prevents productive infection of CFSE-labeled cells. After 6 days
of coculturing, the number of viable CFSE-positive cells is determined by flow cytometry.
(B) Flow cytometry analysis of the mixed HLACs. Indirect killing is determined by gating on live CFSE-positive cells in the mixed cultures. Effector cells are either
infected or uninfected cells.
(C) Extensive depletion of nonproductively infected CD4 T cells by HIV-1. CFSE-labeled cells mixedwith uninfected or infected cells were cultured in the presence
of 5 mMAZT alone or together with 250 nMAMD3100. Data represent live CFSE-positive cells 6 days after coculture with infected or uninfected effector cells. The
absence of productive infection in the CFSE-positive cells was confirmed by internal p24 staining and monitoring GFP expression following infection with the
NLENG1 HIV-1 reporter virus (data not shown).
(D) Preferential depletion of nonproductively infected CD4 T cells by HIV-1. The absolute numbers of viable CFSE-positive CD4 and CD8 T cells and B cells were
determined. Percentages are normalized to the number of viable CFSE-positive cells cocultured with uninfected cells in the presence of AZT, as depicted by an
asterisk. Error bars represent standard deviations of three samples from the same donor. This experiment is representative of more than 10 independent
experiments with more than 10 donors of tonsillar tissues.
See also Figure S1.However, although the number of CD4 T cells was not markedly
altered in infected cultures through six days, the culture was
almost completely devoid of CD4 T cells by day 9. CD8 T cells
were not depleted in infected cultures, and CD4 T cells were
not depleted in uninfected cultures. These findings reveal
marked and selective depletion of CD4 T cells in HLAC cultures.
However, due to the nature of the assay, we could not definitively
conclude whether the principal mechanism of depletion involved
direct or indirect effects of HIV-1.Extensive Depletion of Nonproductively Infected CD4 T
Cells in HLACs
To determine if indirect killing (formerly indicated as ‘‘bystander’’)
of CD4 T cells accounted for most of the observed cellular
depletion, we took advantage of a reported experimental
strategy (Jekle et al., 2003) that unambiguously distinguishes
between the death of productively and nonproductively infected
cells (Figure 2A). After 6 days of coculture, survival analysis
of CFSE-labeled cells by flow cytometry (Figure 2B) showedCell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc. 791
Figure 3. HIV-1 Fusion Is Necessary to Induce Killing of Nonproductively Infected Cells
(A and C) Concentrations of T20 that block viral infection. HLACs were infected with the indicated clones of HIV-1 in the presence of the indicated concentrations
of T20 or no drugs. One hour before incubationwith the virus, cells were pretreated with T20 or left untreated. At 12 hr, cells were washed extensively and cultured
under the same conditions. On day 9, the viral concentration was determined using a p24gag FLAQ assay. The amount of p24gag accumulated in the absence of
drugs by each viral clone (A) or by SKY (C) was defined as 100%.
(B and D) Effect of T20 on indirect killing. CFSE-labeled cells were coculturedwith cells infectedwith the indicated viral clones in the presence of 5 mMAZT and the
indicated concentrations of T20. After 6 days, indirect killing in the mixed cultures was assessed. The number of viable CFSE-positive CD4 T cells cocultured with
uninfected cells in the presence of AZTwas defined as 100% (data not shown). To allow successful initial infection we pseudotyped theGIA-SKYmutants with the
VSV-G envelope. NL4-3,WT lab-adapted virus;WEAU 16-8, primary virus; SIM, T20-resistant virus; GIA-SKY, T20-dependent virus; GIA and SKY, single-domain
mutant viruses. Representative data from three independent experiments with different donors are shown.
See also Figure S2.extensive depletion of CD4 T cells in cultures mixed with HIV-
infected cells but not in those mixed with uninfected cells (Fig-
ure 2C). The relative proportion of CD8 T cells was not altered.
CD3+/CD8– T cells were similarly depleted, indicating that the
loss was not an artifact of downregulated surface expression
of CD4 following direct infection. Loss of CFSE-labeled CD4
T cells was prevented by AMD3100, which blocks the engage-
ment of gp120 with CXCR4, but not by the reverse transcriptase
inhibitor AZT. Thus, productive viral replication is not required for
CD4 T cell death.
To estimate the absolute numbers of all CFSE-labeled cell
subsets, we added a standard number of fluorescent beads
to the cell suspensions (Figure 2D). In contrast to the sharp
decline in CD4 T cells, the absolute numbers of CD8 T and
B cells were unaltered. Separating the HLAC into distinct
cell types revealed that cell death occurred in purified popula-
tions of CD4 T cells suggesting that other cell types did not
mediate the killing. (Figure S1 available online). In all in-
stances, CD4-specific killing was prevented by AMD3100
but not AZT. Importantly, the extent of CD4 T cell depletion
in the presence of AZT was similar to that observed when
no antiviral drugs were added (Figure 2C and Figure 1, re-
spectively). Together, these results suggest that indirect
killing is the predominant mechanism for CD4 T cell depletion
in HIV-infected HLACs.792 Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc.HIV gp41-Mediated Fusion Is Necessary for Depletion
of Nonproductively Infected CD4 T Cells
Studies with AMD3100 andAZT indicated that indirect CD4 T cell
killing is mediated by events occurring between gp120-CXCR4
binding and reverse transcription. Engagement of the chemokine
coreceptor induces conformational changes in gp41, resulting in
insertion of viral fusion peptide on gp41 into the target T cell
membrane. To determine if the gp120-CXCR4 interaction alone
or later events involving viral fusion are required for indirect
killing, we evaluated the effects of enfuvirtide (T20), a fusion
inhibitor that blocks six-helix bundle formation by gp41, a prereq-
uisite for virion fusion and core insertion.
We first determined the optimal concentrations of T20 that
block viral infection (Figure 3A). InNL4-3-infected cells, T20 began
to inhibit infection at concentrations > 2 mg/ml; complete inhibition
required 10 mg/ml. In cells infected with a primary viral isolate,
WEAU 16-8 (Figure S2), infection was completely inhibited by
0.1 mg/ml of T20. T20 did not inhibit infection with a T20-resistant
mutant, SIM (Rimsky et al., 1998), regardless of concentration.
Next, we investigated the effect of T20 on indirect CD4 T cell
killing (Figure 3B). In the absence of T20, high levels of indirect
killing were observed. T20 concentrations that blocked infection
also greatly inhibited indirect killing. T20 did not inhibit indirect
killing in cultures containing SIM-infected cells. Thus, blocking
gp41-mediated fusion prevents indirect killing.
We then examined a T20-dependent mutant, GIA-SKY (Bald-
win et al., 2004), which fuses only when T20 is present, but
cannot initiate a spreading infection in the absence of T20 (Fig-
ure 3C). Consistent with its T20 dependency, in the presence
of 1 mg/ml T20, the GIA-SKY mutant readily replicated while
growth was inhibited at higher or lower T20 concentrations.
The single-domain mutants GIA and SKY exhibited a T20-resis-
tance phenotype similar to that of SIM.
GIA-SKY-infected cells did not induce indirect killing of CD4
Tcells in theabsenceofT20 (Figure3D). Indirectkillingwasobserved
in cultures treated with 1 mg/ml T20 but was inhibited at higher or
lower concentrations. Since T20-dependent viruses were bound
to CXCR4 before T20 was added, these findings argue that
CXCR4 signaling is not sufficient to elicit indirect CD4 T cell killing.
Indirect Killing Requires a Close Interaction between
Uninfected and HIV-Infected Cells
Next we examined whether indirect killing requires close contact
with HIV-infected cells or instead can be fully supported by
virions accumulating in the supernatants of the infected histocul-
tures. We found that cell-free supernatants from HIV-infected
histocultures were much less efficient at inducing indirect killing
(Figure 4A). To exclude the possibility that the concentration of
virions in the supernatants was too low, we repeated this exper-
iment using a 20-fold concentrated virion supernatants (1 mg
p24/ml) but failed to detect indirect CD4 T cell killing (Figure 4B).
Together, these findings suggest that close cell-cell contact is
likely required for indirect killing.
To further explore the potential requirement of close cell-cell
contact for indirect killing (Sherer et al., 2007; Sourisseau et al.,
2007), we repeated these assays using cells that hadbeenwashed
daily with fresh RPMI to prevent accumulation of HIV-1 virions and
soluble factors. Such cell washing did not affect the ability of the
resultant infected cells to mediate indirect CD4 T cell killing (Fig-
ure 4B), suggesting that virions released into the medium do not
participate in indirect killing. We confirmed these findings using
a transwell culture system. CSFE-labeled cells and HIV-infected
cells were mixed or physically separated by a transwell insert with
1 mmpores, which allows free diffusion of virions but not cells. Indi-
rect killingwassubstantial in themixedcultures but not in the trans-
well cultures (Figure 4C). Together, these findings indicate that
indirect killing requires close interaction between CFSE-labeled
and HIV-1-infected cells, consistent with in vitro (Garg et al.,
2007; Holm and Gabuzda, 2005) and in vivo studies showing that
apoptotic nonproductively infected cells in human lymph nodes
often cluster near productively infected cells (Finkel et al., 1995).
Indirect Killing Requires Fusion of Virions
from Nearby HIV-Producing Cells
Indirect killing required gp41-mediated fusion and close interac-
tion with HIV-infected cells, suggesting that cell death may be
caused by the fusion of HIV-1 virions to CD4 T cells, syncytia
formation, or hemifusion (mixing of lipids in the absence of fusion
pore formation) mediated by Env present on HIV-infected cells
interacting with neighboring CD4 T cells. HIV-1 virions (Holm
et al., 2004; Jekle et al., 2003; Vlahakis et al., 2001), cell-medi-
ated fusion (LaBonte et al., 2000; Margolis et al., 1995), and
hemifusion (Garg et al., 2007) have been proposed to be involvedin indirect killing. Therefore, the requirement for cell-cell interac-
tion in indirect killing may bemediated either by effective delivery
of HIV-1 virions or by cell-associated Env.
To discriminate between virion-mediated and cell-associated
Env induction of indirect killing, we tested the effects of HIV
protease inhibitors. These inhibitors act during the budding
process, resulting in immature viral particles that cannot fuse
with target cells (Wyma et al., 2004). We first assessed the effect
of protease inhibitors on viral maturation. NL4-3 viruses carrying
a b-lactamase-Vpr (BlaM-Vpr) reporter protein were produced
in 293T cells in the presence or absence of the HIV protease
inhibitor amprenavir. We also produced a mutant virus, TR712,
encoding a form of gp41 lacking 144 of the 150 amino acids in
the C-terminal cytoplasmic tail. This deletion largely relieves
the impaired fusogenic properties of immature HIV-1 particles
(Wyma et al., 2004). Protein analysis of viral lysates showed
that the NL4-3 and TR712 virions appropriately cleaved gp160
to generate gp120 in the presence and absence of amprenavir.
However, in the presence of amprenavir, an uncleaved form of
p55 Gag polypeptide rather than the mature p24 CA protein
accumulated in both NL4-3 and TR712 virions (Figure 4D). These
results confirm that amprenavir treatment of virus producing
cells results in the accumulation of immature particles containing
normal levels of incorporated Env proteins.
To test the ability of these viruses to fuse with target cells, we
used an HIV virion-based fusion assay that measures b-lacta-
mase (BlaM) activity delivered to target cells upon the fusion
of virions containing BlaM fused to the Vpr protein (BlaM-Vpr)
(Cavrois et al., 2002). Immunoblotting for BlaM confirmed that
NL4-3 and TR712 virions incorporated Blam-Vpr in the presence
or absence of amprenavir (Figure 4D).
Next, SupT1 cells were infected with mature or amprenavir-
treated immature NL4-3 or TR712 virions containing BlaM-Vpr.
Immature NL4-3 viruses displayed a 90% decline in fusogenic
properties (Figure 4E). In contrast, immature TR712 retained
40% fusion capacity, indicating that the impaired fusion is not
a result of a defective BlaM enzyme. Thus, immature virions
generated in the presence of amprenavir display greatly reduced
ability to fuse with target cells. Importantly, protease inhibitors
did not affect the function of Env proteins expressed on infected
cells and did not block cell-cell fusion (Figure S3C).
We next investigated the effect of protease inhibitors on
indirect killing. Remarkably, three different protease inhibitors
inhibited indirect killing as efficiently as AMD3100 (Figure 4F).
These results indicated that HIV-1 virions, not HIV-infected cells,
are responsible for indirect CD4 T cell killing. Additionally, reca-
pitulating the efficient viral delivery of close cell-cell interactions
by spinoculation of free virions resulted in extensive and selec-
tive indirect killing of CD4 T cells while sparing CD8 T cells and
B cells (Figures S3A and S3B). Thus, although indirect killing in
lymphoid cultures requires a close interaction between nonpro-
ductively and productively infected cells, this killing involves
virions rather than cell-associated Env.
Nonpermissive CD4 T Cells Die from Abortive Infection
Based on these findings, we hypothesized that ‘‘indirect killing’’
involves an abortive form of infection, like that which occurs in
nonpermissive resting CD4 T cells. These naive CD4 T cellsCell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc. 793
Figure 4. Killing of Nonproductively Infected CD4 T Cells Requires Fusion of Virions from Nearby HIV-1-Producing Cells
(A) Supernatants from HIV-infected HLACs are less efficient at inducing indirect killing than mixing of HIV-infected and uninfected HLACs.
(B) HIV-1 virions released into themediumdonot participate in indirect killing. Replacing themixed culturewith freshRPMI every 24 hr did not impair indirect killing.
Challenging HLACs with supernatants containing 20-fold more histoculture-derived virions (1 mg p24/ml) than normally accumulated inmixed cultures containing
infected cells (50 ng p24/ml) did not induce indirect killing. Percentages are normalized to the number of viable CFSE-positive cells depicted by an asterisk.
(C) CFSE-labeled cells are not killed when HIV-infected HLAC is physically separated by a 1 mm –pore transwell system that allows free diffusion of HIV-1 parti-
cles. Values represent the levels of viable CFSE-positive cells after 6 days of culture in the presence of the indicated drugs. Red, HIV-infected cells; blue, unin-
fected cells; green, CFSE-labeled cells.
(D) Mature and immature viruses carry equivalent amounts of envelope protein and Blam-Vpr, but differ in their content of capsid and Gag precursor. NL4-3 and
TR712 viruses were generated in 293T cells with or without amprenavir, lysed and subjected to SDS-PAGE immunoblotting analysis for gp120, p55 Gag, p24 CA,
Blam-Vpr, and free Blam.
(E) Immature viruses have reduced capacity to enter cells. SupT1 cells were mock infected or infected with mature or immature NL4-3 or TR712 virions con-
taining Blam-Vpr. After loading of cells with CCF2 dye, fusion was analyzed by flow cytometry. Percentages are the fraction of cells displaying increased cleaved
CCF2 fluorescence, indicating virion fusion.
(F) Protease inhibitors inhibit indirect killing. CFSE-labeled cells were cocultured with NL4-3-infected or uninfected cells in the presence of AZT (5 mM) alone or
together with AMD3100 (250 nM). To the indicated cultures were added 5 mM of amprenavir, saquinavir, or indinavir. Percentages are normalized to the number
of viable CFSE-positive cells depicted by an asterisk. Error bars represent the SD obtained with three independent samples from the same donor.
See also Figure S3.exhibit an early post-entry block to HIV-1 infection that can be
relieved by activation with phytohemagglutinin (PHA) and inter-
leukin-2 (IL-2) (Kreisberg et al., 2006; Santoni de Sio and Trono,794 Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc.2009; Unutmaz et al., 1999; Zack et al., 1990). To test this
hypothesis, we compared the killing of activated and nonacti-
vated CFSE-labeled cells in HLACs.
Figure 5. Death of Abortively Infected CD4 T Cells Is Due to Impaired Reverse Transcription
(A) Status of mixed HLACs containing either resting or activated CFSE-labeled cells, 4 days after coculturing with effector cells. Activated CFSE-labeled cells
were stimulated with PHA and IL-2 48 hr before mixing, but not during coculturing with effector cells. To avoid direct killing of activated CFSE-labeled cells in
cultures with no drugs, cell killing was terminated and analyzed 4 days after coculturing.
(B) AZT renders activated CFSE-labeled CD4 T cells sensitive to indirect killing. Resting or activated CFSE-labeled cells were cocultured with effector cells in the
presence of no drugs, AZT (5 mM) alone, or AZT and AMD3100 (250 nM). Data are from two independent experiments performedwith tonsil cells from two different
donors.
(C) AZT-induced killing is lost when AZT-resistant viruses are tested. Resting or activated CFSE-labeled cells were cocultured with cells infected with NL4-3 or
HIV-1 clones #629 and #964 in the presence of no drugs, AZT (0.5 mM) alone, or AZT and AMD3100 (250 nM). AZT-sensitive and AZT-resistant sub-clones are
depicted. Data are representative of three independent experiments with three different donors.
(D) NNRTIs prevent killing of abortive infected CD4 T cells. Resting or activated CFSE-labeled cells were cocultured with infected or uninfected effector cells, in
the presence of no drugs, AZT (5 mM), AMD3100 (250 nM), the NNRTIs efavirenz (100 nM), and nevirapine (1 mM), or the integration inhibitors raltegravir (30 mM)
and 118-D-24 (60 mM). Killing of resting CFSE-labeled CD4 T cells was blocked with equal efficiency by NNRTIs and AMD3100 (columns 15, 16), but not by
integration inhibitors (columns 17, 18). In combination, NNRTIs prevented cell death induced by AZT in activated CFSE-labeled cells (compare column 38 to
44 and 45). Data are representative of four independent experiments with four different donors.
The absolute numbers of CFSE-labeled CD8 T cells and B cells was unaltered in these experiments (data not shown). Percentages are normalized to the number
of viable CFSE-positive cells depicted by an asterisk.
See also Figure S4.CFSE-labeled cells were activatedwith PHA and IL-2 two days
before mixing with effector cells, and contained a large
percentage of dividing CD25 and CD69 positive cells. Nonacti-
vated (resting) CFSE-labeled cells did not divide and typicallycontained a small percentage of cells expressing CD25 and
CD69 (Figure 5A). Either in the presence or absence of AZT,
killing of resting CFSE-labeled CD4 T cells was robust (Figure 5B,
columns 4 and 5, and 16 and 17). In sharp contrast, activatedCell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc. 795
Figure 6. Cytoplasmic HIV-1 DNA Triggers Proapoptotic and Proinflammatory Responses in Abortively Infected CD4 T Cells
(A) Critical reactions in HIV-1 reverse transcription as detected by probesmonitoring different regions within the Strong stop, Nef, and Env DNA fragments. RDDP,
RNA-dependent DNA polymerase. Adapted from S.J. Flint et al., Principles of Virology, 2000 ASM Press, Washington DC, with permission.
(B) NNRTIs prevent accumulation of DNA elongation products. The amount of viral DNA detected by a particular probe was calculated as a fold change relative
to cells treated with no drugs (i.e., calibrator). A bactin probe was used as an internal reference. Mean cycle threshold (Ct) values of calibrator samples are
depicted. CD4 T cells were infected with WT NL4-3 produced in 293T cells, or with a Dvif NL4-3 collected from supernatants of infected HLAC, as described
in Figure S4C. Data are representative of two independent experiments performed with cells from two different donors.
(C and D) Abortive HIV-1 infection generates a coordinated proapoptotic and proinflammatory response involving caspase-3 and caspase1 activation. HLACs
were spinoculated with no virus or with NL4-3 and AZT (5 mM), Efavirenz (100 nM), and T20 (10 mg/ml), as indicated (see Figures S3A and S3B). After 3 days, cells
were assessed by flow cytometry for intracellular levels of proinflammatory cytokines, serine 37 phosporylated p53, and activated caspases as indicated.
Ethidiummonoazide was used to exclude dead and necrotic cells from the annexinV binding analysis. Data are representative of three independent experiments
with three different donors.
(E) Death of abortively infected CD4 T cells requires caspase activation. CSFE-labeled cells were cocultured with effector cells in the presence of 20 mMof Z-VAD-
FMK,ageneral caspase inhibitor,or Z-FA-FMK,anegativecontrol for caspase inhibitors.AZT (5mM);AMD3100 (250nM).Percentagesarenormalized to thenumber
of viable CFSE-positive cells depicted by an asterisk. Error bars represent standard error of the mean of three experiments from three different HLAC donors.
(F) Abortive HIV infection promotes the maturation and secretion of IL-1b in tonsillar CD4 T cells. Isolated tonsillar CD4 T cells were either untreated, or stimulated
with PMA (phorbol-12-myristate-12-acetate, 0.5 mM) and the potassium ionophore nigericin (10 mM), or spinoculated with or without NL4-3 in the presence of
796 Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc.
CFSE-labeled CD4 T cells were not depleted in the absence of
AZT, but were extensively depleted in cultures containing AZT
(Figure 5B, columns 10 and 11 and 22 and 23). Addition of
AMD3100 prevented the AZT-induced killing of activated
CFSE-labeled cells, excluding nonspecific toxic effects of AZT
in the activated cells (Figure 5B, columns 12 and 24).
The ability of AZT to promote indirect killing of activated CD4
T cells suggested that cell death is triggered by impaired reverse
transcription. To investigate this possibility, we repeated the
experiment with two pairs of AZT-resistant HIV-1 clones, 629
and 964 (Larder et al., 1989). We first determined that concentra-
tions of 0.5 mM AZT block viral replication in NL4-3-infected and
AZT-sensitive clones and achieve half maximal inhibitory effect
in AZT-resistant clones (Figures S4A and S4B).
When resting CFSE-labeled cells were used, the extent of
killing by the AZT-resistant HIV-1 viruses was similar to that
obtained with NL4-3 with or without AZT (Figure 5C resting
CFSE-positive cells), demonstrating a redundant function for
endogenous termination of reverse transcription and AZT. Alter-
natively, when activated CFSE-labeled cells were tested, AZT-
resistant HIV-1 clones did not deplete CFSE-labeled CD4
T cells in the presence of AZT (Figure 5C, columns 29 and 35).
Death of Abortively Infected CD4 T Cells Is Triggered
by Premature Termination of Viral DNA Elongation
We next asked what stage of reverse transcription triggers abor-
tive infection cell death. AZT inhibits DNA elongation but not
early DNA synthesis (Arts and Wainberg, 1994). We therefore
examined whether blocking early DNA synthesis with nonnu-
cleoside reverse transcriptase inhibitors (NNRTIs) would have
the same effect as AZT. Impaired reverse transcription may
also lead to abortive integration, causing chromosomal DNA
breaks and a genotoxic response. To exclude this possibility,
we used integrase inhibitors. To discriminate between the cyto-
pathic response induced by endogenous termination of reverse
transcription and the response induced by AZT, we separately
assessed resting and activated CFSE-labeled cells.
Remarkably, the NNRTIs, efavirenz and nevirapine, blocked
indirect killing of resting CD4 T cells as efficiently as AMD3100
(Figure 5D, columns 15 and 16). These findings suggested that
allosteric inhibition of reverse transcriptase induced by these
NNRTI’s interrupts reverse transcription sufficiently early to
abrogate the death response. In contrast, the integrase inhibitors
raltegravir and 118-D-24 did not prevent abortive infection killing
(Figure 5D, columns 17 and 18), suggesting that cell death
involves signals generated prior to viral integration. NNRTIs
also protected activated CFSE-labeled cells from death induced
by AZT (Figure 5D, column 38 versus columns 44 and 45),AZT (5 mM), AMD3100 (250 nM), and efavirenz (100 nM) as indicated. After 3 days
ysis. On day 5, the supernatants from the rest of the cells were collected and sub
pro-IL-1b (37kD) and the mature cleaved form (17kD). Data are the representativ
from five different donors.
(G) DNA reverse transcription intermediates induce an IFN-stimulatory antiviral inn
HIV-1 reverse transcription intermediate products as indicated by numbers (detail
acid [poly(I:C)], and were analyzed by flow cytometry after 48 hr. Data are repre
independent samples from the same experiment.
See also Figure S5 and Figure S6.demonstrating that a certain degree of DNA synthesis is required
to elicit the cytopathic response.
This notion was further strengthened in findings obtained with
vif-deficient (Dvif) HIV-1 particles where reverse transcription is
inhibited during strong-stop DNA synthesis due to incorporated
APOBEC3G (A3G) (Bishop et al., 2008; Li et al., 2007). Abortively
infected CD4 T cells were not depleted by Dvif NL4-3-infected
cells (Figures S4C and S4D), indicating that termination of
reverse transcription before the completion of strong-stop
DNA synthesis is not sufficient to generate a cytopathic
response. Other HIV-1 mutants containing substitutions in
RNase H and nucleocapsid that promote early defects in reverse
transcription failed to elicit indirect CD4 T cell killing (Figures S4E
and S4F). Together, these findings indicate that accumulation of
reverse-transcribed DNA, rather than any inherent activity of the
HIV-1 proteins, is the key factor that triggers the death response.
Abortively Infected CD4 T Cells Commence
but Do Not Complete Reverse Transcription
We next examined the status of HIV-1 reverse transcription in
tonsillar CD4 T cells after infection. Specifically, we investigated
the effect on reverse transcription after treatment with NNRTIs,
such as efavirenz and nevirapine, which prevent the death of
abortively infected CD4 T cells, or with AZT or integrase inhibitor
(raltegravir) that do not prevent CD4 T cell death. Taqman-based
quantitative real-time PCR (QPCR) was used to quantify the
synthesis of reverse transcription products in isolated CD4
T cells from HLAC 16 hr after infection with NL4-3. We designed
specific QPCR primers and probes (Table S1) to monitor
sequential steps in reverse transcription including generation
of strong-stop DNA, first template exchange (Nef), and DNA
strand elongation (Env) (Figure 6A). Reverse transcription
products corresponding to strong-stop DNA were similar in
untreated CD4 T cells or cells treated with AZT, NNRTIs, or
raltegravir but were greatly reduced in cells treated with
AMD3100 or in cultures infected with Dvif NL4-3 where arrest
occurs prior to the completion of strong-stop DNA synthesis
(Figure 6B columns 1–8). In contrast, the accumulation of later
reverse transcription products detected by the Nef and Env
probes were dramatically inhibited by the NNRTIs but not by
raltegravir. Levels of Nef (Figure 6B, columns 10 and 11) and
Env (columns 18 and 19) DNA products were similar in untreated
cells and cells treated with AZT, indicating that reverse transcrip-
tion in most tonsillar CD4 T cells naturally terminates during DNA
chain elongation, coinciding with the block induced by AZT. The
minor inhibition detected by AZT is likely due to a small number
of permissive CD4 T cells in the culture. These results show that
abortively infected CD4 T cells accumulate incomplete reverse, half of the cells were lysed and subjected to SDS-PAGE immunobloting anal-
jected to SDS-PAGE immunobloting analysis. The IL-1b antibody detects the
e results of five independent experiments using tonsillar CD4 T cells isolated
ate immune response (ISD). ISRE-GFP reporters were transfected with 1 mg of
ed description in Figure S5E), empty DNA plasmid, or polyinosinic:polycytidylic
sentative of three independent experiments; error bars show the SD for three
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transcription products representative of DNA strand elongation.
Blocking earlier steps of reverse transcription by NNRTIs or by
genetic mutations like deletion of Vif or mutation of RNase H
restricts accumulation of such products, and prevents abortive
infection-induced cell death (Figure S6A).
DNA Reverse Transcription Intermediates Elicit
a Coordinated Proapoptotic and Proinflammatory
Response in Abortively Infected CD4 T Cells
We next evaluated whether HIV-mediated indirect killing of CD4
T cells is associated with deregulation of cytokine production or
a DNA damage response. To facilitate a vigorous and synchro-
nized killing effect, HLACs were spinoculated with NL4-3 virions
in the presence of various antiviral drugs. Interestingly, based on
immunostaining after cytokine capture, abortively infected CD4
T cells expressed IFN-b, and high levels of the proinflammatory
interleukin 1b (IL–1b), but not tumor necrosis factor (TNFa)
(Figure 6C). Phosphorylation of S37 p53 was not observed,
suggesting that abortive HIV-1 infection does not induce a
DNA damage cascade. Abortively infected CD4 T cells also
displayed caspase-1 and caspase-3 activity along with appear-
ance of annexin V (Figure 6D). T20 and efavirenz but not AZT
prevented activation of these caspases, indicating that apo-
ptosis was induced by abortive HIV-1 infection. Cell death was
completely prevented by Z-VAD-FMK, a pan-caspase inhibitor,
suggesting that caspase activation is required for the observed
cytopathic response (Figure 6E). Suchmode of cytokine produc-
tion and caspase activation was not observed in CD8 T or B cells
(Figures S5B and S5C).
We next examined whether abortive HIV-1 infection signals for
the maturation and secretion of IL-1b. In cells, IL–1b activity is
rigorously controlled. Cells can be primed to express inactive
pro-IL-1b by various proinflammatory signals. However, the
release of bioactive IL-1b requires a second signal leading to
activation of inflammasomes, cleavage of pro-IL-1b by caspase
1 and secretion of the bioactive 17 kDa form of IL-1b (Schroder
and Tschopp, 2010). Interestingly, Western blot analysis re-
vealed high amounts of intracellular pro-IL-1b in untreated CD4
T cells, suggesting that tonsillar CD4 T cells are primed to release
proinflammatory mediators (Figure 6F). Stimulating the CD4
T cells with PMA and nigericin induced further accumulation
of pro-IL-1b and promoted the maturation and release of the
bioactive 17 kDa IL-1b into the supernatant. Remarkably, infec-
tion of CD4 T cells with NL4-3 in the presence of AZT similarly
resulted in maturation and release of the bioactive 17 kDa
IL-1b into the supernatant. This response was completely pre-
vented by efavirenz and AMD3100, suggesting that abortive
HIV-1 infection signals the maturation and release of bioactive
IL-1b in these CD4 T cells.
To identify the nature of the nucleic acid species that trigger
these responses, we used a recently described H35 rat hepato-
cyte cell line containing an IFN-sensitive response element
(ISRE) linked to GFP (Patel et al., 2009). H35 cells were first
infected with pseudotyped VSV-G HIV-1 virions. These virions
induced GFP expression and cell death in the presence or
absence of AZT. Importantly, the expression of GFP and cell
death response were blocked by efavirenz but not raltegravir
(Figure S5D). Thus, the H35 system successfully reconstitutes798 Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc.the cytokine and cytopathic response observed in tonsillar
CD4 T cells. We next synthesized the various HIV-1 reverse
transcription intermediates and tested their ability to activate
the ISRE-GFP reporter. Interestingly, none of the RNA-contain-
ing oligonucleotides stimulated the ISRE-GFP reporter expres-
sion above baseline. In sharp contrast, ssDNA and dsDNA
oligonucleotides longer than 500 bases in length, which corre-
sponded to reverse transcription intermediates produced during
DNA elongation, evoked a potent ISRE-GFP activation (Fig-
ure 6G). Similarly, when cells were stimulated with poly(I:C), a
synthetic double-stranded RNA known to activate IRF3 via the
RIG-I pathway elicited a comparable ISRE-GFP response. Taken
together, these findings indicate that reverse transcription
intermediates generated during DNA chain elongation induce
a coordinated proapoptotic and proinflamatory innate immune
response involving caspase-3 and caspase-1 activation in
abortively infected CD4 T cells.
DISCUSSION
Themechanism through which HIV-1 kills CD4 T cells, a hallmark
of AIDS, has been a topic of vigorous research and one of the
most pressing questions for the field over the last 28 years
(Thomas, 2009). In this study, we investigated the mechanism
of HIV-1-mediated killing in lymphoid tissues, which carry the
highest viral burdens in infected patients. We used HLACs
formedwith freshhuman tonsil cells andanexperimental strategy
that clearly distinguishes between direct and indirect mecha-
nisms of CD4 T cell depletion. We now demonstrate that indirect
cell killing involving abortive HIV infection of CD4 T cells accounts
for the vast majority of cell death occurring in lymphoid tissues.
No more than 5% of the CD4 T cells are productively infected,
but virtually all the remaining CD4 T cells are abortively infected
ultimately leading to caspase-mediated cell death. Equivalent
findings were observed in HLACs formed with fresh human
spleen (Figures S6B and S6C), indicating this mechanism of
CD4 T cell depletion can be generalized to other lymphoid
tissues.
Themassive depletion of nonproductively infected CD4 T cells
is in contrast to their survival after infection of intact blocks of
tonsillar tissue in human lymphoid histoculture (HLH) (Grivel
et al., 2003). This result probably reflects differences between
the HLH and the HLAC experimental systems. In HLH, the com-
plex three-dimensional spatial cellular organization of lymphoid
tissue is preserved, but cellular movement and interaction are
restricted, both of which are required for indirect killing. In
HLAC, the tissue is dispersed, andcells are free to interact, result-
ing in a rapid and robust viral spread. While the mechanism
triggering indirect CD4 T cell death is certainly identical in both
settings, HLH allows only a slow, nearly undetectable progres-
sion of indirect CD4 T cell death. In HLAC, this process is accel-
erated, allowing the outcome to be detected in a few days. Inter-
estingly, indirect killing was also less efficient when peripheral
bloodcellswere tested (datanot shown). It is possible that cellular
factors specifically produced in lymphoid organs are required to
accelerate indirect killing of peripheral blood CD4 T cells.
Several mechanisms have been proposed to explain indirect
CD4 T cell killing during HIV infection. Our finding that CD4
Figure 7. Consequences of Inhibiting Early Steps of HIV-1 Infection on CD4 T Cell Death
(A) The nonpermissive state of most CD4 T cells in lymphoid tissue leads to endogenous termination of reverse transcription during DNA chain elongation (i.e.,
‘‘killing zone’’). As a result, DNA intermediates accumulate in the cytoplasm and elicit a multifaceted proapoptotic and proinflammatory innate immune defense
programs, coordinated by IFN-stimulatory DNA (ISD) response, caspase-3, caspase-1, and IL-1b, to restrict viral spread. Different classes of antiretroviral drugs
act at different stage of the HIV life cycle. NNRTIs like efavirenz and nevirapine inhibit early steps of DNA synthesis and therefore prevent such response and the
consequence CD4 T cell death. AZT is less efficient at blocking DNA synthesis and therefore unable to abrogate this response.
(B) In permissive CD4 T cells reverse transcription proceeds, allowing HIV-1 to bypass the ‘‘killing zone’’ and move on to productive (or latent) infection.
Interrupting reverse transcription with AZT traps the virus in the ‘‘killing zone’’ and induces cell death. EFV, efavirenz; NVP, nevirapine; and RTGR, raltegravir.
See also Figure S6.T cell death is blocked by entry and fusion inhibitors but not by
AZT, strongly suggested that such killing involves nonproductive
infection of CD4 T cells. Therefore, we focused on events that
occur after HIV-1 entry. Our investigations demonstrate that
abortive viral DNA synthesis occurring in nonpermissive, quies-
cent CD4 tonsil T cells, plays a key role in the cell death
response. Conversely, in the small subset of permissive target
cells, reverse transcription is not interrupted, minimizing the
accumulation and subsequent detection of such reverse
transcription intermediates (Figure 7).
Interrupted or slowed reverse transcription may create persis-
tent exposure to cytoplasmic DNAproducts that elicit an antiviral
innate immune response coordinated by activation of type I IFNs
(Stetson and Medzhitov, 2006). Such activation, termed
IFN-stimulatory DNA (ISD) response, may be analogous to the
type I IFN response triggered by the RIG-I-like receptor (RLR)
family of RNA helicases that mediate a cell-intrinsic antiviraldefense (Rehwinkel andReis e Sousa, 2010). Our results suggest
that abortive HIV-1 infection also stimulates activation of
caspase-3, which is linked to apoptosis, and caspase-1, which
promotes the processing and secretion of the proinflammatory
cytokines like IL–1b. It is certainly possible that pyroptosis
elicited in response to caspase-1 activation also contributes to
the observed cytopathic response (Schroder and Tschopp,
2010). The release of inflammatory cytokines during CD4 T cell
death could also contribute to the state of chronic inflammation
that characterizes HIV infection. This inflammation may fuel
further viral spread by recruiting uninfected lymphocytes to the
inflamed zone. While this innate response was likely designed
to protect the host, it is subverted in the case of HIV infection
and importantly contributes to the immunopathogenic effects
characteristic of HIV infection and AIDS.
Such antiviral pathways comprise an unrecognized cell-
intrinsic retroviral detection system (Manel et al., 2010; StetsonCell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc. 799
et al., 2008). Viral RNA in infected cells is recognized by
members of the RIG-I-like family of receptors that detect specific
RNA patterns like uncapped 50 triphosphate (Rehwinkel and
Reis e Sousa, 2010). Although uncapped RNA intermediates
are generated by the HIV-1 RNase H, they contain a 50 mono-
phosphate and therefore may be not recognized by the RIG-I
system (Figure 6G). In contrast to RNA receptors, intracellular
sensing of viral DNA remains poorly understood. Consequently,
it is unclear how HIV-1 DNA intermediates are detected in the
cytoplasm of abortively infected CD4 T cells. AIM2 (absent in
melanoma 2) was recently identified as a cytoplasmic dsDNA
receptor that induces cell death in macrophages through activa-
tion of caspase-1 in imflammasomes (Hornung et al., 2009). Our
preliminary investigations have not supported a role for AIM2 in
cell death induced by abortive HIV infection (data not shown),
suggesting the potential involvement of a different DNA-sensing
mechanism. We also have not identified a role for TLR9 and
MYD88 signaling in this form of cell death. Additional candidate
sensors recognizing cytoplasmic HIV-1 DNA are now under
study.
In summary, both productive and nonproductive forms of HIV
infection contribute to the pathogenic effects of this lentivirus.
The relative importance of these different cell death pathways
might well vary with the stage of HIV infection. For example,
direct infection and death might predominate during acute
infection where CCR5-expressing memory CD4 T cells in gut-
associated lymphoid tissue are effectively depleted. Conversely,
the CXCR4-dependent indirect killing we describe in tonsil tissue
may reflect later stages of HIV-induced disease where a switch
to CXCR4 coreceptor usage occurs in approximately 50% of
infected subjects.
The current study demonstrates how a cytopathic response
involving abortive viral infection of resting nonpermissive CD4
T cells can lead not only to CD4 T cell depletion but also to the
release of proinflammatory cytokines. The ensuing recruitment
of new target cells to the site of inflammation may fuel a vicious
cycle of continuing infection and CD4 T cell death centrally
contributing to HIV pathogenesis.
EXPERIMENTAL PROCEDURES
Culture and Infection of HLACs
Human tonsil or splenic tissues were obtained from the National Disease
Research Interchange and the Cooperative Human Tissue Network and pro-
cessed as previously described (Jekle et al., 2003). For a detailed description
see Extended Experimental Procedures.
FACS Analysis and Gating Strategy, Preparation of HIV-1 Virions,
and Virion-Based Fusion Assay
Data were collected on a FACS Calibur (BD Biosciences) and analyzed with
Flowjo software (Treestar). HIV-1 viruses were generated by transfection of
proviral DNA into 293T cells by the calcium phosphate method. Virion-based
fusion assay was performed as previously described (Cavrois et al., 2002).
Detailed protocols are provided in the supplemental experimental procedures.
Spinoculation and Taqman-Based QPCR Analysis
of HIV-1-Infected CD4 T Cells
The spinoculation method is described in detail in Figures S3A and S3B.
Isolation of HLAC CD4 T cells and QPCR protocol are described in detail
in supplemental experimental procedures. Primers and probes sequences
used to detect reverse transcription products are provided in Table S1.800 Cell 143, 789–801, November 24, 2010 ª2010 Elsevier Inc.QPCR reactions were performed in an ABI Prism 7900HT (Applied
Biosystems).
ISRE-GFP H35 Reporter Cells, Microscopy, and Generation
of Synthetic HIV-1 Reverse Transcription Intermediates
H35 rat hepatic cells containing an ISRE-GFP reporter were maintained as
described (Patel et al., 2009). For microscopy imaging, ISRE-GFP reporter
H35 cells were infected with a replication competent VSV-G pseudotyped
NL4-3 and analyzed using an Axio observer Z1 microscope (Zeiss). Transfec-
tions and generation of synthetic HIV-1 reverse transcription intermediates are
described in detail in Figure S5E and Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures,
six figures, and one table and can be found with this article online at
doi:10.1016/j.cell.2010.11.001.
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